Format

Send to

Choose Destination
Breast. 2017 Jun;33:159-165. doi: 10.1016/j.breast.2017.03.008. Epub 2017 Apr 7.

Reirradiation for locally recurrent breast cancer.

Author information

1
Department of Radiation Oncology, Hospital Sírio-Libanês and Department of Radiology and Oncology of University of São Paulo, Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP), Brazil. Electronic address: gustavo.marta@hc.fm.usp.br.
2
Division of Radiation Oncology, McGill University Health Centre, Montréal, Canada. Electronic address: tarek.hijal@mcgill.ca.
3
Department of Radiation Oncology, Hospital Sírio-Libanês and Department of Radiology and Oncology of University of São Paulo, Instituto de Radiologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil. Electronic address: heloisa.carvalho@hc.fm.usp.br.

Abstract

The aim of this study is to review the current status of reirradiation therapy (Re-RT) for locally recurrent breast cancer. The overall outcome of breast/chest wall Re-RT is difficult to assess because of the wide range of different treatments that a patient may have undergone and the patient's individual features. The local control and complete response rates were reported to be 43-96% and 41-71%, respectively. The combination of Re-RT and hyperthermia seems to be related to improved outcomes. Toxicity rates vary between studies, and Re-RT is generally well tolerated. Re-RT may be considered an option for patients with breast cancer relapse after prior irradiation. Further studies are needed to determine the best irradiation volume and treatment modality for patients with locally recurrent disease.

KEYWORDS:

Breast cancer; Radiation therapy; Recurrence; Reirradiation; Treatment

PMID:
28395234
DOI:
10.1016/j.breast.2017.03.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center